Myeloma Clinical Trials

171 clinical trials for Myeloma across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluation of Skin Tests in Biotherapy Allergies — RECRUITING · NA
• A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma — RECRUITING · PHASE1
• Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation — RECRUITING · PHASE2
• A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma — RECRUITING · PHASE1
• A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties — RECRUITING · NA
• Pilot Imaging Study of Leukemia — RECRUITING · PHASE1
• Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care — RECRUITING · NA
• Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy — RECRUITING · NA
• A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment — RECRUITING · PHASE2
• Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM — RECRUITING · PHASE1
• Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma — RECRUITING · PHASE2
• Liquid Biopsy Evaluation and Repository Development at Princess Margaret — RECRUITING
• Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) — RECRUITING · PHASE2
• Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) — RECRUITING · PHASE2
• Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) — RECRUITING · PHASE2
• Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) — RECRUITING · PHASE2
• HEME Home Transfusion Program — RECRUITING · NA
• A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma — RECRUITING · PHASE2
• PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) — RECRUITING · PHASE2
• Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients — RECRUITING · PHASE1
• Bergamo Lymphoid Cancer Registry — RECRUITING
• European Rare Blood Disorders Platform (ENROL) — RECRUITING
• A RANDOMIZED, PHASE 3, OPEN LABEL STUDY EVALUATING SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF ISATUXIMAB IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN ADULT PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM) — RECRUITING · PHASE3
• A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION — RECRUITING · PHASE3
• A RANDOMIZED PHASE II, OPEN LABEL STUDY OF DARATUMUMAB, WEEKLY LOW-DOSE ORAL DEXAMETHASONE AND CYCLOPHOSPHAMIDE WITH OR WITHOUT POMALIDOMIDE IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA — RECRUITING · PHASE2
• Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma — ACTIVE_NOT_RECRUITING · PHASE2
• Rutgers University Study of the Genetics of Blood Cancers — NOT_YET_RECRUITING
• Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma — NOT_YET_RECRUITING · PHASE1
• Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy — ACTIVE_NOT_RECRUITING · PHASE2
• Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma — ACTIVE_NOT_RECRUITING · NA
• REal World MAIA UK OutcomEs — NOT_YET_RECRUITING
• Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma — ACTIVE_NOT_RECRUITING · PHASE2
• Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years — COMPLETED · PHASE3
• Maintenance Therapy Using Lenalidomide in Myeloma — COMPLETED · PHASE3
• Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy — COMPLETED · NA
• CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years). — ACTIVE_NOT_RECRUITING · PHASE3
• PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study — ACTIVE_NOT_RECRUITING · PHASE1
• Removing Transfusion Dependence as a Barrier to Hospice Enrollment — COMPLETED · NA
• Non-invasive MRD Assessment in Multiple Myeloma — COMPLETED
• A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. — COMPLETED · PHASE2
• Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults — COMPLETED · PHASE4
• Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning — COMPLETED · PHASE2
• FT576 in Subjects With Multiple Myeloma — COMPLETED · PHASE1
• Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy — COMPLETED · PHASE1
• Stem Cell Transplantation for Patients With Multiple Myeloma — COMPLETED · PHASE1
• Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients — COMPLETED
• Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT — COMPLETED · PHASE1
• The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss — COMPLETED

Refine this search